347 related articles for article (PubMed ID: 24944134)
21. Body composition, fatigue and exercise in patients with prostate cancer undergoing androgen-deprivation therapy.
Newton RU; Jeffery E; Galvão DA; Peddle-McIntyre CJ; Spry N; Joseph D; Denham JW; Taaffe DR
BJU Int; 2018 Dec; 122(6):986-993. PubMed ID: 29750398
[TBL] [Abstract][Full Text] [Related]
22. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
[TBL] [Abstract][Full Text] [Related]
23. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation.
Galvão DA; Taaffe DR; Spry N; Joseph D; Turner D; Newton RU
Prostate Cancer Prostatic Dis; 2009; 12(2):198-203. PubMed ID: 18852703
[TBL] [Abstract][Full Text] [Related]
24. Low bone density and high percentage of body fat among men who were treated with androgen deprivation therapy for prostate carcinoma.
Chen Z; Maricic M; Nguyen P; Ahmann FR; Bruhn R; Dalkin BL
Cancer; 2002 Nov; 95(10):2136-44. PubMed ID: 12412167
[TBL] [Abstract][Full Text] [Related]
25. Football training in men with prostate cancer undergoing androgen deprivation therapy: activity profile and short-term skeletal and postural balance adaptations.
Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Helge EW; Schmidt JF; Brasso K; Helge JW; Jakobsen MD; Andersen LL; Rørth M; Midtgaard J; Krustrup P
Eur J Appl Physiol; 2016 Mar; 116(3):471-80. PubMed ID: 26620651
[TBL] [Abstract][Full Text] [Related]
26. Evidence for reduced neuromuscular function in men with a history of androgen deprivation therapy for prostate cancer.
Girard D; Marino FE; Cannon J
Clin Physiol Funct Imaging; 2014 May; 34(3):209-17. PubMed ID: 24119067
[TBL] [Abstract][Full Text] [Related]
27. Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy.
Wilson RL; Newton RU; Taaffe DR; Hart NH; Lyons-Wall P; Galvão DA
Med Sci Sports Exerc; 2021 Mar; 53(3):470-478. PubMed ID: 33009195
[TBL] [Abstract][Full Text] [Related]
28. Community-based football in men with prostate cancer: 1-year follow-up on a pragmatic, multicentre randomised controlled trial.
Bjerre ED; Petersen TH; Jørgensen AB; Johansen C; Krustrup P; Langdahl B; Poulsen MH; Madsen SS; Østergren PB; Borre M; Rørth M; Brasso K; Midtgaard J
PLoS Med; 2019 Oct; 16(10):e1002936. PubMed ID: 31574097
[TBL] [Abstract][Full Text] [Related]
29. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer.
Smith MR
Urology; 2004 Apr; 63(4):742-5. PubMed ID: 15072892
[TBL] [Abstract][Full Text] [Related]
30. Football Compared with Usual Care in Men with Prostate Cancer (FC Prostate Community Trial): A Pragmatic Multicentre Randomized Controlled Trial.
Bjerre ED; Brasso K; Jørgensen AB; Petersen TH; Eriksen AR; Tolver A; Christensen JF; Poulsen MH; Madsen SS; Østergren PB; Borre M; Krustrup P; Johansen C; Rørth M; Midtgaard J
Sports Med; 2019 Jan; 49(1):145-158. PubMed ID: 30506427
[TBL] [Abstract][Full Text] [Related]
31. Effect of football or strength training on functional ability and physical performance in untrained old men.
Andersen TR; Schmidt JF; Nielsen JJ; Randers MB; Sundstrup E; Jakobsen MD; Andersen LL; Suetta C; Aagaard P; Bangsbo J; Krustrup P
Scand J Med Sci Sports; 2014 Aug; 24 Suppl 1():76-85. PubMed ID: 24903323
[TBL] [Abstract][Full Text] [Related]
32. Moderators of the effects of exercise training in breast cancer patients receiving chemotherapy: a randomized controlled trial.
Courneya KS; McKenzie DC; Mackey JR; Gelmon K; Reid RD; Friedenreich CM; Ladha AB; Proulx C; Vallance JK; Lane K; Yasui Y; Segal RJ
Cancer; 2008 Apr; 112(8):1845-53. PubMed ID: 18306372
[TBL] [Abstract][Full Text] [Related]
33. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
[TBL] [Abstract][Full Text] [Related]
34. Decrease in lean body mass in men with prostate cancer receiving androgen deprivation therapy: mechanism and biomarkers.
Hara N; Ishizaki F; Saito T; Nishiyama T; Kawasaki T; Takahashi K
Urology; 2013 Feb; 81(2):376-80. PubMed ID: 23374809
[TBL] [Abstract][Full Text] [Related]
35. Mediators of the resistance and aerobic exercise intervention effect on physical and general health in men undergoing androgen deprivation therapy for prostate cancer.
Buffart LM; Galvão DA; Chinapaw MJ; Brug J; Taaffe DR; Spry N; Joseph D; Newton RU
Cancer; 2014 Jan; 120(2):294-301. PubMed ID: 24122296
[TBL] [Abstract][Full Text] [Related]
36. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
Preston DM; Torréns JI; Harding P; Howard RS; Duncan WE; McLeod DG
Prostate Cancer Prostatic Dis; 2002; 5(4):304-10. PubMed ID: 12627216
[TBL] [Abstract][Full Text] [Related]
37. Does Use of Androgen Deprivation Therapy (ADT) in Men with Prostate Cancer Increase the Risk of Sarcopenia?
Owen PJ; Daly RM; Dalla Via J; Mundell NL; Livingston PM; Rantalainen T; Fraser SF
Calcif Tissue Int; 2019 Oct; 105(4):403-411. PubMed ID: 31317232
[TBL] [Abstract][Full Text] [Related]
38. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
Elife; 2024 Apr; 13():. PubMed ID: 38656229
[TBL] [Abstract][Full Text] [Related]
39. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study.
Hansen PA; Dechet CB; Porucznik CA; LaStayo PC
PM R; 2009 Nov; 1(11):1019-24. PubMed ID: 19942188
[TBL] [Abstract][Full Text] [Related]
40. High-intensity training following lung cancer surgery: a randomised controlled trial.
Edvardsen E; Skjønsberg OH; Holme I; Nordsletten L; Borchsenius F; Anderssen SA
Thorax; 2015 Mar; 70(3):244-50. PubMed ID: 25323620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
